These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 21265011)

  • 1. Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia.
    van Schie RM; Brüggemann RJ; Hoogerbrugge PM; te Loo DM
    J Antimicrob Chemother; 2011 Aug; 66(8):1853-6. PubMed ID: 21652620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ileus induced by the combination of vinca alkaloids and posaconazole in a patient with acute lymphoblastic leukemia: a case report and literature review.
    Li Y; Gong YH; Zhao MF; Xiao X; Wei XC
    J Int Med Res; 2023 Aug; 51(8):3000605231193823. PubMed ID: 37622457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vincristine-Induced Seizure from Drug Interactions: A Case Report and Review of Literature.
    Heidari S; Panahishokouh M; Babakhani D; Aghabeigi S; Vaezi M; Amini S; Hadjibabaie M; Shahrami B
    Case Rep Oncol; 2023; 16(1):363-371. PubMed ID: 37384200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mold-Active Antifungal Prophylaxis in Pediatric Patients with Cancer or Undergoing Hematopoietic Cell Transplantation.
    Lehrnbecher T; Bochennek K; Groll AH
    J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Gabapentin and Amitriptyline in the Treatment of Refractory Chemotherapy-Induced Peripheral Neuropathy in a Toddler.
    Alalade E; Owusu-Bediako K; Tobias JD
    J Med Cases; 2021 Dec; 12(12):495-498. PubMed ID: 34970373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
    Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology: A Randomized Controlled Trial Comparing Push Injections with One-Hour Infusions (The VINCA Trial).
    van de Velde ME; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van den Berg MH
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of risk-adapted and mould-specific antifungal prophylaxis in childhood leukaemia.
    Meryk A; Kropshofer G; Hutter J; Fritz J; Salvador C; Lass-Flörl C; Crazzolara R
    Br J Haematol; 2020 Dec; 191(5):816-824. PubMed ID: 32621534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.
    Benitez LL; Carver PL
    Drugs; 2019 Jun; 79(8):833-853. PubMed ID: 31093949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive Fungal Disease in Children with Acute Leukemia: The Elusive Culprit.
    Totadri S; Bansal D
    Indian J Pediatr; 2018 Dec; 85(12):1059-1060. PubMed ID: 30328082
    [No Abstract]   [Full Text] [Related]  

  • 11. Advances in the Treatment of Mycoses in Pediatric Patients.
    Iosifidis E; Papachristou S; Roilides E
    J Fungi (Basel); 2018 Oct; 4(4):. PubMed ID: 30314389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of two non-myasthenic patients with ptosis.
    Kırık S; Güngör O; Işıkay S; Acıpayam C; Çoban Y; Çelik E
    Turk Pediatri Ars; 2017 Dec; 52(4):240-243. PubMed ID: 29483806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
    Yang L; Yu L; Chen X; Hu Y; Wang B
    Med Sci Monit; 2015 Jun; 21():1656-61. PubMed ID: 26050202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azole interactions with multidrug therapy in pediatric oncology.
    Ruggiero A; Arena R; Battista A; Rizzo D; Attinà G; Riccardi R
    Eur J Clin Pharmacol; 2013 Jan; 69(1):1-10. PubMed ID: 22660443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse interactions between antifungal azoles and vincristine: review and analysis of cases.
    Moriyama B; Henning SA; Leung J; Falade-Nwulia O; Jarosinski P; Penzak SR; Walsh TJ
    Mycoses; 2012 Jul; 55(4):290-7. PubMed ID: 22126626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of azole-enhanced vincristine neurotoxicity in pediatric patients with hematological malignancies: old problem - new dilemma.
    Pana ZD; Roilides E
    Pediatr Blood Cancer; 2011 Jul; 57(1):30-5. PubMed ID: 21265011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports.
    Chan JD
    Pharmacotherapy; 1998; 18(6):1304-7. PubMed ID: 9855331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective analysis of neurotoxicity induced by vinca alkaloids combined with azole anti-fungal agents in hematological malignancies].
    Osato Y; Yokoyama T; Saito Y; Kani R; Hayabe H; Miyamatsu H; Ohyashiki K
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1667-72. PubMed ID: 21996963
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.